Pulse ← Library
Sales Book Summaries · book-summary

Solution Selling by Michael Bosworth — Cliff Notes Summary & Key Takeaways

👁 0 views📖 2,987 words⏱ 14 min read5/31/2026

Direct Answer

Solution Selling by Michael T. Bosworth (McGraw-Hill, 1994) and its 2003 successor The New Solution Selling by Keith M. Eades (McGraw-Hill, 2003) are the books that taught two generations of B2B reps to diagnose before prescribing.

Bosworth's central claim — *"Sellers create buyers — buyers don't create themselves"* — argued that a prospect is not actually ready to buy until the rep has walked them from Latent Pain (a problem they don't see) to Acknowledged Pain (a problem they admit but won't act on) to a Vision of a Solution (a future state they can see in enough detail to validate, negotiate, and sign).

The signature artifact is the 9-Box Pain Sheet — a 3x3 matrix of Pain / Reason for Pain / Capabilities Required crossed with three diagnostic depths (Open, Control, Confirm) that a rep fills out live during discovery. Eades's 2003 rewrite kept the architecture, modernized the language, and added a tighter Power-Sponsor / Sponsor / Coach access map plus an explicit Value Justification worksheet that monetized the cost of inaction.

Solution Selling is the spine of every consultative method that came after — Rackham's SPIN (1988) feeds it; Bosworth & Holland's CustomerCentric Selling (2003), Eades's The New Solution Selling (2003), and Dixon & Adamson's Challenger Sale (2011) all argue with it; and MEDDPICC (operationalized by Darius Lahoutifard and Andy Whyte's 2020 book) still uses Bosworth's "Identified Pain" criterion as a core qualification gate.

1. Part One — The Buying Process (Chapters 1-3)

1.1 Chapter 1 — Sellers Create Buyers

Bosworth opens with a punch at the prevailing 1980s sales orthodoxy: most training assumed the buyer arrived already convinced they needed the product and the rep's job was to out-feature, out-price, or out-relationship the competition. Bosworth's field data — drawn from his work at Xerox and his consulting practice Solution Selling Inc. (later folded into Sales Performance International) — showed the opposite.

The vast majority of qualified prospects are not actively shopping. They live with chronic pain they have learned to tolerate.

The rep's real job, Bosworth argues, is to manufacture buyer readiness — to take a prospect from "we're managing" to "we have to fix this now" to "this specific solution is the one." This is the chapter that earned Bosworth his most-quoted line: "No pain, no change — no change, no sale."

1.2 Chapter 2 — The Three Levels of Buyer Need

The framework that organizes the entire book:

Bosworth's claim: a Vision of a Solution is what buyers actually buy — not features, not price, not the rep's personality. Reps who try to close before the Vision is built lose to "no decision."

1.3 Chapter 3 — Why Most Reps Fail

Bosworth profiles the rep behaviors that block diagnosis: premature presentation (pulling out the deck before the pain is developed), happy ears (hearing "interesting" as "yes"), and feature-dumping (reciting capabilities the buyer cannot yet map to a problem). The chapter closes with the data point that drove a generation of sales VPs to buy the book in bulk: roughly half of forecasted enterprise deals end in "no decision" rather than a competitive loss — because the buyer never reached Vision.

2. Part Two — The 9-Box Pain Sheet (Chapters 4-6)

2.1 Chapter 4 — Diagnosing Pain

The 9-Box Pain Sheet is Bosworth's signature instrument. Three rows: Pain, Reason for Pain, Capabilities Required to relieve pain. Three columns of escalating diagnostic depth: Open (open-ended exploration), Control (the rep narrows the discussion to specific symptoms), Confirm (the rep restates and gets the buyer to agree).

The rep's discovery call is structured to fill in every one of the nine cells before any product positioning happens. If a cell is empty at the end of the call, the rep has not yet earned the right to present.

2.2 Chapter 5 — Developing Vision

Once Pain and Reason for Pain are confirmed, the rep walks the buyer through scenario questions — "If you had a way to know within 24 hours that a deal was slipping, who would use it? What would they do with the alert? How would that change your forecast accuracy?" — designed to let the buyer construct their own Vision with the rep as guide.

The buyer's words become the spec.

Bosworth is emphatic: the Vision must be in the buyer's language, not the rep's. A buyer who hears their own words played back will defend the Vision internally; a buyer who hears the rep's pitch will not.

2.3 Chapter 6 — Reference Stories

The Reference Story is the structured case-study narrative Bosworth pioneered: *"Company A had Pain B. The Reason was C. They needed Capability D. With our help they achieved Outcome E."* Used early in the call as a pattern-match trigger — the prospect sees themselves in Company A and self-identifies their own latent pain.

Modern descendants include Gong's "snippet libraries" and Chorus's deal-pattern callouts, which surface the same Reference Story structure inside post-call summaries.

3. Part Three — Access to Power (Chapters 7-9)

3.1 Chapter 7 — Power-Sponsor, Sponsor, Coach

Bosworth maps the buying committee into three roles the rep must work in sequence:

The book's prescription: never present to a Sponsor without a documented agreement to be introduced to the Power Sponsor. A deal that stalls at Sponsor level is a deal the rep already lost.

3.2 Chapter 8 — Negotiating Access

Bosworth introduces the "quid pro quo" letter — a written summary the rep sends to the Sponsor after diagnosis, restating the 9-Box findings and explicitly requesting access to the Power Sponsor as the condition for proceeding. The letter forces the Sponsor to either escalate or kill the deal — both of which are better than indefinite stalling.

This chapter is where Solution Selling earned its reputation as operational, not aspirational. The Sponsor letter template is reprinted verbatim in the appendix.

3.3 Chapter 9 — Qualifying Out

Bosworth devotes an entire chapter to qualifying deals OUT — walking away from prospects who refuse to grant Power Sponsor access, who cannot articulate Pain at the Confirm level, or who lack the budget authority to act. The discipline is hard: most reps refuse to disqualify because pipeline coverage looks better with the bad deals in.

Bosworth's counterargument: bad deals consume the time you need to win good ones, and the forecast accuracy lost to "no decision" deals is the single largest hidden cost in most sales orgs.

4. Part Four — Value Justification and Control of the Sale (Chapters 10-12)

4.1 Chapter 10 — Value Justification

Solution Selling pioneered the explicit ROI worksheet that became standard B2B procurement practice. The arithmetic is simple and brutal:

Eades's 2003 revision tightened this into a Value Justification Worksheet the rep co-fills with the buyer's CFO — making the buyer's own finance team the author of the business case. The seller's name does not appear on the spreadsheet.

4.2 Chapter 11 — Controlling the Buying Process

Bosworth argues the rep should own the buying process the buyer will follow, because most buyers have not bought this category before and have no native process to lean on. The rep proposes the evaluation criteria, the proof-of-concept design, the reference call sequence, and the contract negotiation timeline.

The buyer almost always says yes — because the buyer has no better alternative to propose.

The control mechanism is the Evaluation Plan — a written, mutually-signed document listing every step from current state through contract signature, with dates and owners. Mutual Action Plans in modern tools like Dock, Aligned, and Recapped are direct descendants.

4.3 Chapter 12 — Negotiation and Close

The final chapter argues that negotiation is what happens when diagnosis failed. A buyer with a fully built Vision and a CFO-signed Value Justification rarely negotiates aggressively on price — the math has already won. Aggressive price negotiation is a tell that the rep skipped pain development or never reached the Power Sponsor.

Bosworth's close is procedural, not theatrical: confirm the Evaluation Plan was completed, confirm the Vision matches the proposed solution, confirm the Value Justification math, ask for the order. No "always be closing" — just the natural conclusion of a well-run diagnosis.

5. The Eades 2003 Revision — What Changed

Keith M. Eades took over the Solution Selling franchise after Bosworth left Sales Performance International in the late 1990s. *The New Solution Selling* (McGraw-Hill, 2003) made three substantive updates:

The architecture is unchanged. A 1994 Bosworth rep and a 2003 Eades rep run the same play.

Solution Selling Architecture

flowchart TD A[Prospect with Latent Pain] --> B[Rep Diagnoses with 9-Box Pain Sheet] B --> C{Pain / Reason / Capabilities all confirmed?} C -->|No| D[Disqualify or restart discovery] C -->|Yes| E[Acknowledged Pain reached] E --> F[Develop Vision of a Solution<br/>in buyer's language] F --> G[Sponsor letter requests<br/>Power Sponsor access] G --> H{Power Sponsor access granted?} H -->|No| D H -->|Yes| I[Value Justification<br/>co-built with CFO] I --> J[Evaluation Plan signed] J --> K[Proof / References / Contract] K --> L[Negotiation = math has already won] L --> M[Close]

Frameworks at a Glance

Solution Selling Operating Loop

flowchart LR A[Pre-call planning<br/>hypothesis + Reference Story] --> B[Diagnose pain<br/>9-Box discovery call] B --> C[Create vision<br/>scenario questions] C --> D[Build proof<br/>POC + references] D --> E[Justify value<br/>CFO worksheet] E --> F[Negotiate<br/>Evaluation Plan execution] F --> G[Close<br/>natural conclusion] G --> A

What Holds Up, What Has Aged

What holds up perfectly. The diagnosis-before-prescription discipline is bulletproof. The "no pain, no change" gate has aged into the single most important qualification rule in B2B selling, and **Matthew Dixon's 2022 follow-up *The JOLT Effect* essentially proved Bosworth right at scale — Dixon's research on 2.5 million sales calls showed that 40-60% of forecasted enterprise deals die to indecision**, not competition.

Bosworth saw this in 1994. The Power Sponsor access discipline is also aging beautifully — every modern qualification framework (MEDDPICC, Force Management's Command of the Message, Winning by Design's SPICED) explicitly codifies "Economic Buyer" or "Decision Maker" access as a gate.

What has aged. The 9-Box Pain Sheet as a literal artifact has been replaced operationally by Gong call summaries, Clari deal boards, Outreach Kaia notes, and MEDDPICC qualification fields inside the CRM. Reps rarely fill out a physical Pain Sheet — but every modern tool encodes the same diagnostic structure underneath.

The bigger challenge came from **Matthew Dixon and Brent Adamson's *The Challenger Sale* (2011), which argued that the post-2008 enterprise buyer did not want to be diagnosed — they had already done their own diagnosis online and wanted the rep to Challenge** them with insight the buyer had not yet seen.

The honest 2027 read is both/and: insight-led teaching opens the door, but diagnostic depth still wins the deal. Modern best-in-class methods (Force Management, Winning by Design) blend both.

The Eades-era Sponsor letter has been replaced by Mutual Action Plans in Dock, Aligned, and Recapped — same instrument, modern packaging.

FAQ

Is Solution Selling still relevant in 2027? Yes — the diagnosis discipline is the spine of every modern consultative method. The literal artifacts (9-Box Pain Sheet, Sponsor letter) have been replaced by software, but the underlying play is unchanged. Read Bosworth to understand *why* the play works; use modern tools to run it.

Bosworth or Eades — which book should I read? Read Eades 2003 first. The language is cleaner, the buying-cycle awareness is sharper, and the manager-coaching chapter is the bridge to MEDDPICC. Then read Bosworth 1994 for the original ideological argument and the Reference Story chapter.

How is Solution Selling different from SPIN Selling? Neil Rackham's SPIN (1988) is the question-asking technique (Situation, Problem, Implication, Need-Payoff) that *Bosworth assumes the rep already knows*. Solution Selling is the architecture wrapped around SPIN — Power Sponsor access, Reference Story, Value Justification, Evaluation Plan.

SPIN is the discovery toolkit; Solution Selling is the deal operating system.

How does Solution Selling map to MEDDPICC? Cleanly. Bosworth's "Identified Pain" = MEDDPICC's Identified Pain. His Power Sponsor = the Economic Buyer.

His Value Justification = Metrics. His Evaluation Plan = the Paper Process. His Coach = the Champion.

Andy Whyte's 2020 MEDDPICC book explicitly credits Bosworth as a foundation source.

What did Challenger Sale get right that Solution Selling missed? That the buyer of 2011 had access to information the buyer of 1994 did not. Bosworth's diagnostic walk assumed an information-poor buyer who needed the rep to surface Latent Pain. The 2011 enterprise buyer arrived having already self-diagnosed online — so the rep needed to add value by teaching the buyer something the buyer's research missed.

The modern synthesis (Gong Labs, Winning by Design) does both: open with insight, then diagnose for depth.

Is the 9-Box Pain Sheet worth using as a literal template? As a coaching tool — yes. New reps benefit enormously from being forced to fill in all nine cells before presenting. As an in-call artifact — no. Use the CRM's MEDDPICC fields or Gong's post-call analysis. The structure survived; the paper template did not.

Bottom Line

Solution Selling invented modern consultative B2B selling. Every framework that came after it — SPIN's question-asking, Challenger's teaching, MEDDPICC's qualification, Force Management's value framing, Winning by Design's SPICED — is either building on Bosworth's architecture or arguing with it.

Read Eades 2003 for the cleanest modern version, then implement the play through whatever software stack you already own. The 9-Box Pain Sheet is now a Clari field; the Sponsor letter is now a Dock Mutual Action Plan; the Reference Story is now a Gong snippet. The play is unchanged: diagnose before you prescribe, get to the Power Sponsor, co-author the business case, and never present above the buyer's current need level.

Sources

Keep reading
Download:
Was this helpful?  
⌬ Apply this in PULSE
Gross Profit CalculatorModel margin per deal, per rep, per territory
Related in the library
More from the library
tech-stack · revops-toolsWhat is the recommended API Security Vendor sales and operations tech stack in 2027?revops · current-events-2027How do you detect LLM jailbreaks in production in 2027?sales-training · sales-meetingAI Video Generation Selling to the Video Production Lead — 60-Min Trainingtech-stack · revops-toolsWhat is the recommended AI Translation API sales and operations tech stack in 2027?graphic · linkedin-bannerAI Legal Operator — LinkedIn Bannertech-stack · revops-toolsWhat is the recommended Computer Vision API sales and operations tech stack in 2027?revops · current-events-2027How do you select an embedding model for RAG in 2027?sales-training · sales-meetingGenAI Platform Selling to the Enterprise CIO — 60-Min Trainingbook-summary · cliff-notesSPIN Selling by Neil Rackham — Cliff Notes & Chapter-by-Chapter Summarybook-summary · cliff-notesFrom Impossible to Inevitable by Aaron Ross and Jason Lemkin — Cliff Notes Summarysales-training · sales-meetingSynthetic Data Selling to the Head of Data Science — 60-Min Trainingtech-stack · revops-toolsWhat is the recommended AI Video Generation sales and operations tech stack in 2027?tech-stack · revops-toolsWhat is the recommended AI Code Review sales and operations tech stack in 2027?tech-stack · revops-toolsWhat is the recommended AI Recruiting sales and operations tech stack in 2027?